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Perspectives of practising pharmacists towards interprofessional 1 education and collaborative practice in Qatar 2 
3 
Abstract 4 
Background. Healthcare is provided by a variety of different professionals, including 5 
pharmacists who are integral members of the team, and all are expected to work 6 
collaboratively to provide quality care.  Little is known about the perceptions of pharmacists in 7 
Qatar towards interprofessional collaboration. Positive attitudes towards interprofessional 8 
education are essential to successful implementation of interprofessional collaboration. 9 
Therefore, to develop effective collaboration strategies in practice settings, it was essential to 10 
survey the attitudes of practising pharmacists towards collaboration. 11 
Objective: To explore the awareness, views, attitudes and perceptions of practising 12 
pharmacists in Qatar towards interprofessional education and collaborative practice. 13 
Setting: Community, hospital and primary healthcare settings in Qatar. 14 
Methods: This was a two-staged sequential explanatory mixed method design. It utilised a 15 
quantitative survey (Stage 1), based on a modified version of the Readiness for 16 
Interprofessional Learning Scale. This was followed by a qualitative stage, utilising focus 17 
groups (Stage 2). 18 
Main outcome measures included: 1) Qatar pharmacists' attitudes towards interprofessional 19 
education and collaborative practice; 2) Practising pharmacists’ perspectives in relation to 20 
enablers, barriers and recommendations regarding interprofessional education and 21 
collaborative practice. 22 
Results: Sixty three percent of the practising pharmacists (n=178) responded to the survey. 23 
Three focus groups followed (total n=14). High scores indicating readiness and positive 24 
attitudes towards interprofessional education were reported for pharmacists working in 25 
hospital, community and primary healthcare settings. Qualitative analysis identified three 26 
overarching themes in relation to the enablers, barriers and recommendations for practising 27 
pharmacists working collaboratively. The enabling themes were: professional and patient 28 
related benefits, and current positive influences in Qatar; the barriers were patients’ negative 29 
perceptions; the status of the pharmacy profession and current working practices and 30 
processes; the recommendations related to improving patients’ perceptions about 31 
pharmacists and enhancing the status of pharmacy profession in Qatar. The findings from this 32 
study highlighted two major observations: the lack of existence of collaborative practice and 33 
hierarchy and power play. 34 
Conclusion: Pharmacists demonstrated willingness and readiness to develop interprofessional 35 
learning and collaborative practice with significant steps already taken towards improving 36 
collaborative working practices in different care settings. 37 
38 
39 
40 
41 
2 
Introduction 42 
Healthcare is provided by a number of different professionals, including pharmacists who are 43 
integral members of the healthcare team, and there is an expectation for all professionals to 44 
work collaboratively and provide quality care [1, 2]. The role of the pharmacist has significantly 45 
evolved, beyond the dispensing of medication, since the introduction of Hepler and Strand’s 46 
concept of pharmaceutical care in early nineties. This change corresponds with developments 47 
in extensive training and expertise within the profession and the demand for complex 48 
medication management. [3, 4, 1, 5, 6]. A key factor in successful implementation of 49 
pharmaceutical care is the collaboration between pharmacists and other members of the 50 
healthcare team i.e. interprofessional collaboration [7]. 51 
A number of definitions for interprofessional collaboration (IPC) exist [8-10, 6]. In many of 52 
these definitions, keys concepts of collaboration stem from shared responsibilities, collective 53 
decisions, interprofessional communication, accountability, and education [11]. One example 54 
is the definition from the International Pharmaceutical Federation where Collaborative 55 
Pharmacy Practice (CPP) is defined as ‘advanced clinical practice where pharmacists 56 
collaborate with other healthcare professionals to care for patients, carers and public’. This 57 
includes ‘initiation, modification and monitoring of prescription medicine therapy; ordering and 58 
performing laboratory and related tests, assessing patient response to therapy; counselling, 59 
educating partnering with patients regarding their medications and administering medications’ 60 
[6] p. 6-7. The World Health Organisation and International Pharmaceutical Federation in a61 
joint document called for increased interprofessional working and advocated that pharmacists 62 
need to assume new roles and responsibilities to function as collaborative members of the 63 
healthcare team [1]. 64 
Pharmacists are assuming greater patient-centred care responsibilities [12, 1, 5]. These 65 
responsibilities include medication management and review; chronic disease management; 66 
medication reconciliation; disease prevention; immunisation services; health promotion 67 
programmes; education; prescribing; and interprofessional clinical care based on shared 68 
decision making and grounded on evidence-based practice [4, 2]. Collaboration with the 69 
healthcare team requires diverse skills, expertise and attitudes. Pharmacists are required to 70 
adopt approaches that effectively integrate healthcare teams. These include: being 71 
accessible, visible, competent, confident, committed, and responsible when working with other 72 
healthcare professionals [1]. Previous studies have demonstrated the evidence of the benefits 73 
of pharmacists’ collaboration with other healthcare professionals in improving patient care and 74 
in decreasing medical errors [13-16, 5, 17]. 75 
The preponderance of previous research has largely focused on exploring the relationship 76 
between community pharmacists and general practitioners [18-25], and also on primary care 77 
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and inpatient settings [26-28].  A recent systematic review has highlighted the positive 78 
attitudes that pharmacy students, practicing pharmacists and faculty had towards 79 
Interprofessional Education (IPE) and IPC. Five main findings have been identified from this 80 
review: heterogeneity in reporting IPE research, the traditional professional image of the 81 
pharmacist, lack of longitudinal research follow-up, lack of IPE research on faculty and a 82 
paucity in mixed method studies [29]. 83 
It is worth highlighting that pharmacists in developing countries are still struggling to gain 84 
recognition for their role and are considered underutilised. [30, 31, 7]. This paper will focus on 85 
pharmacy practice in Qatar which has evolved in the last 10 years. The establishment of the 86 
first and only College of Pharmacy in Qatar with full accreditation from the Canadian Council 87 
on Accreditation of Pharmacy Programs (CCAPP), and the recent advancements in the role 88 
of the pharmacists especially in the country’s hospital sector have contributed significantly. 89 
These include a pharmacist-managed anticoagulation clinic [32-34], pharmacist delivered 90 
discharges with a tailored follow-up in patients with Acute Coronary Syndrome [35], clinical 91 
pharmacy services in palliative care, hospital emergency department and neonatal intensive 92 
care unit [36-38], and a pharmacist delivered smoking cessation program in Qatar [39]. 93 
Furthermore, IPE which is defined as ‘two or more professions learning with, from and about 94 
each other to improve collaboration and the quality of care’ [40], is an important element in the 95 
accreditation standard for pharmacy for CCAPP. Similar to healthcare professionals in Qatar, 96 
pharmacists practising in Qatar are a heterogeneous expatriate group from diverse 97 
backgrounds with most pharmacists graduating from Egypt, Jordan, India, Sudan and 98 
Pakistan [41]. Pharmacy programmes in these countries heavily focus on pharmaceutical 99 
sciences and industry rather than on clinical pharmacy [42]. Little is known about the 100 
perceptions of pharmacists in Qatar towards interprofessional collaboration (IPC). Therefore, 101 
to develop effective collaboration strategies in practice settings, it is essential to survey the 102 
attitudes of practising pharmacists towards collaboration as positive attitudes towards IPE are 103 
essential for successful implementation of IPC [43].  104 
Aim of the study 105 
The aim of this study was to explore the awareness, views, attitudes and perceptions of 106 
practising pharmacists in Qatar towards IPE and collaborative practice.  107 
Ethics approval 108 
The study was approved by Qatar University (QU) Institutional Review Board (QU-IRB 228-109 
E/13), Doha, Qatar  and the Robert Gordon University (RGU) School of Pharmacy and Life 110 
Sciences Research Ethics Committee (RGU-6-June-2013), Aberdeen UK.  111 
4 
Methods 112 
A two-staged sequential explanatory mixed method design was used to capture 113 
comprehensive perspectives of practising pharmacists toward IPE and IPC through a 114 
quantitative survey (Stage 1) followed by - qualitative focus groups (Stage 2). 115 
Stage 1: Quantitative Survey 116 
A self-administered online English survey was created in Snap 10 Professional. The survey 117 
included a modified version of the validated tool ‘Readiness for Interprofessional Learning 118 
Scale (RIPLS) [44]. This is a 23-item 5-point Likert scale (strongly disagree (1), to strongly 119 
agree (5)) divided into three subscales: teamwork & collaboration, sense of professional 120 
identity and patient-centredness. The maximum total score was 115 and the minimum total 121 
score was 23. Higher score indicated more positive attitudes. However, this study’s objectives 122 
proposed to gain greater breadth and depth than the RIPLS would generate. Therefore, further 123 
questions from previous studies [45] and experiences, were added to the survey. To assess 124 
the content and face validity of the amended survey, the survey was piloted among 10 125 
practising pharmacists from the various practice settings in Qatar. Following the piloting 126 
phase, minor modifications were made to the survey questions to improve clarity, organization 127 
and flow of questions. Pharmacists involved in the pilot were excluded from the main study 128 
results. 129 
As there were no up-to-date lists or databases of practising pharmacists in Qatar, the College 130 
of Pharmacy in Qatar University database, which has been used in previous published 131 
research was employed [46]. This database contained 557 pharmacists at the time of the 132 
study. Using Raosoft ® online sample size calculator [47], a recommended sample size of 228 133 
was calculated to achieve a confidence level of 95% and a margin of error of 5% considering 134 
50% response distribution. To account for non-response rate, a 25% increase to the sample 135 
size was considered. Consequently, the recommended sample size was 285, which was 136 
randomly selected. The selected sample received an invitation email to take part in this study. 137 
Statistical analysis was completed in Statistical Package for Social Sciences, version 22 (IBM 138 
SPSS® Statistics for Windows; IBM Corp, Armonk, New York, USA) using descriptive and 139 
inferential statistics. Examples of tests included one-way between-groups ANOVA and a 140 
series of independent t-tests. 141 
Stage 2: Qualitative focus group 142 
Three focus groups were conducted in English, with the different groups of practising 143 
pharmacists (community, hospital, and primary care). Each focus group lasted around 2 hours. 144 
Only respondents from the survey who indicated their willingness to participate in a focus 145 
group were invited. This provided a sampling pool and allowed the principal researcher to 146 
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purposively select a sample that included an equal distribution of representatives from the 147 
different pharmacy settings. The principal researcher sent the invitations to participants by 148 
email along with an information leaflet about the study. A reminder email was sent to interested 149 
participants again a week before the focus group’s scheduled date. Over-recruiting of 150 
participants has been recommended as a strategy to control for any potential absences [48, 151 
49]. In this study, focus groups ranged from 4 to 6 participants per group which concurred with 152 
best practices [50]. 153 
A moderator guide to structure the discussion was developed with guiding questions for the 154 
focus groups (Table 1). Focus groups were conducted in the same format to allow for potential 155 
comparison between groups during the analysis. Prior to the commencement of each focus 156 
group, all participants provided written signed consent. An independent experienced 157 
transcriber transcribed the audio files verbatim and these were verified and validated by the 158 
principal researcher. Thematic analysis was undertaken on the transcripts [51]. The principal 159 
researcher reviewed all the transcripts several times and coded the data and extracted the 160 
main emerging themes. A second investigator reviewed the transcripts and the key themes 161 
thus strengthening the validation of study results. All authors met thereafter to discuss the 162 
coding, similarities and differences until consensus was reached on the key themes and 163 
subthemes. 164 
165 
Results 166 
Stage 1 167 
The response rate for the survey was 178/285 (63%). Just over half of the respondents were 168 
male (52%, n=93). Eighty-eight percent (n=157) of the respondents were aged between 25 169 
and 44 years old. The majority were working in hospital settings (38%, n=67), with an equal 170 
distribution of respondents between community and primary care settings. More than 70% of 171 
respondents had worked in Qatar from 1 to 10 years. More than two thirds of the respondents 172 
(67%, n=119) were qualified and obtained their highest pharmacy degree more than five years 173 
ago (table 2). Most respondents were from: Egypt (30%, n=54), India (21%, n=37), Sudan 174 
(12%, n=21) and Philippines (11%, n=19). Most respondents interacted with physicians (91%, 175 
n=162), followed by pharmacists (87%, n=154), and less than three-quarters of the 176 
respondents interacted with nurses (71%, n=127). 177 
The respondents were asked to rank the responses that best reflected their beliefs about 178 
factors affecting their IPC. Respondents gave their highest score to the importance of IPC to 179 
the effectiveness of their work. However, pharmacists gave their lowest rating to satisfaction 180 
with the process of IPC in their work settings. Additionally, respondents believed that they 181 
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understood other professionals’ scope of practice much more than other professionals 182 
understood the pharmacists’ scope of practice (Table 3). Compared with pharmacists in 183 
hospital and primary healthcare settings, community pharmacists reported that other 184 
professionals understood the least about their scope of practice, that they had less 185 
administrative support, and that they were less satisfied with IPC. Hospital pharmacists gave 186 
their lowest rating to issues of confidentiality limiting their IPC and primary care pharmacists 187 
reported that students, clients, and patients expected them to collaborate less than community 188 
and hospital pharmacists. There was a significant difference between responses to the 189 
question ‘How much do issues of confidentiality limit IPC?’ (p = 0.034). Post hoc testing using 190 
Tukey’s test revealed that there was a significant difference between hospital pharmacists (M 191 
= 2.88, SD = 1.078) and community pharmacists (M = 3.30, SD = 0.933), F(2,170) = 3.459, p 192 
= 0.058. 193 
Table 4 highlights the seven items relating to respondents’ self-assessment of their IPC 194 
knowledge and skills from the highest to lowest mean scores. Overall, respondents rated their 195 
knowledge much less than their skill level. Over a third of the respondents (34%, n=60) rated 196 
their knowledge of IPC models and research as poor. More than a quarter of the respondents 197 
(27%, n=48) rated their skills level for communicating effectively as satisfactory or poor. 198 
Respondents ranked four potential barriers that may prevent them from attending an IPE 199 
training with the barrier of ‘time’ being ranked as the highest, followed by ‘financial and travel 200 
limitations’ and lastly lack of administrative support. 201 
 RIPLS scale for practising pharmacists202 
Overall RIPLS scores were high among hospital, community, and primary healthcare 203 
pharmacists indicating high readiness and better attitudes (Table 5). Cronbach's alpha for the 204 
23 statements in the RIPLS scale was 0.809. There was a significant difference between 205 
responses to the question ‘the function of nurses and therapists is mainly to provide support 206 
for doctors’ (p = 0.018). Post hoc analysis using Tukey’s test revealed hospital respondents 207 
(M = 2.75, SD = 1.318) scored significantly lower than community respondents (M = 3.36, SD 208 
= 1.025), F(2,169) = 4.101, p = 0.019. 209 
IPE definition 210 
Although 60% (n=106) of the respondents were aware of the term IPE, only 39% (n=70) could 211 
identify the correct statement. Less than a quarter (21%, n=37) of the respondents had 212 
previous experience of IPE. Just over half of the respondents (56%, n=100) could identify the 213 
correct statement for IPC (Table 6). When t-tests were carried out, there was a significant 214 
difference between the means on subscale 1, teamwork and collaboration, when respondents 215 
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correctly identified which statement described IPE (M = 57.23, SD = 6.04) compared to 216 
respondents who did not (M = 59.20, SD = 5.51), t(160) = -2.10, p = 0.037 (Table 5).  217 
Effect of gender 218 
In the analysis of RIPLS subscales, female pharmacists had higher mean scores on team 219 
collaboration and patient-centredness than male pharmacists. t-tests demonstrated a 220 
significant effect of gender on teamwork and collaboration. Females scored higher (M = 59.33, 221 
SD = 4.96) than males (M= 56.87, SD = 6.41), t(160) = 2.70, p = 0.008. There was no 222 
significant effect of gender on the two other subscales, with p greater than 0.05. 223 
Stage 2 224 
Three focus groups were convened for practising pharmacists: community pharmacists (n=4), 225 
hospital pharmacists (n=6) and primary healthcare (n=4). These further explored the 226 
perceptions and experiences of the different participants concerning IPE, collaborative 227 
practice. Three overarching themes were identified related to  pharmacists’ perceptions of the 228 
enablers, barriers, and recommendations for the implementation of IPE and collaborative 229 
practice as shown in Table 7.  230 
 Pharmacists’ perceptions of enablers 231 
Focus group participants discussed various advantages for implementing IPE and 232 
collaborative practice. They were categorised under three different themes.  233 
Firstly, participants identified professional related benefits of having collaborative practice at 234 
their settings and this was perceived to ease interprofessional communication. Participants 235 
identified that appreciation and trust by the other healthcare professions will translate to 236 
increased self-confidence when working in a team compared to working individually. There 237 
was also the enrichment of practice experience and the opening of new horizons for practising 238 
pharmacists as one community pharmacist mentioned: 239 
“Interprofessional working can take pharmacists to different new areas opening up new sectors 240 
for pharmacists, professions” (Community Pharmacist Participant 1). 241 
The second theme highlighted was patient related benefits where participants repeatedly 242 
emphasised that the ultimate focus for all healthcare professionals is positive patient 243 
outcomes, so all professionals should work effectively together to achieve this. When working 244 
interprofessionally, participants perceived there should be a reduction of errors including 245 
medication errors as all the healthcare professions aim to provide safer environments for 246 
patient care as illustrated by the below quotation. 247 
“What is your expertise? What is their expertise? and collectively what you’re going to do for 248 
patients. To serve high quality or the best quality service to a patient. Also, it is necessary to 249 
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reduce errors to reduce any signs of negative or bad things in treatment ... Collectively 250 
integrating different efforts by healthcare professionals will produce a more effective treatment 251 
care to the patient” (Primary Care Pharmacist Participant 1). 252 
253 
The third theme was the current positive influences driving change towards collaborative 254 
practice in Qatar. Participants noted that there have been many improvements in the last three 255 
years. These include: the Qatar National Vision with the prospect of greater opportunities for 256 
pharmacists and healthcare professionals; accreditations for hospital and primary care 257 
settings that will deliver the highest standard of quality healthcare; the recent transformation 258 
of the pharmacist role moving from being product-focused to being patient-focused. One 259 
clinical pharmacist explained: 260 
“At the beginning, it was very challenging and because there were few clinical pharmacists, 261 
they were not covering all the teams. They had a big load of patients and so a lot of their 262 
intervention was not noticed that much. However, the current situation is quite different and we 263 
have a good base of clinical pharmacists and the role of the clinical pharmacist is much more 264 
obvious, their role is well-accepted and other healthcare professionals are looking for them” 265 
(Clinical Pharmacist Participant 1). 266 
267 
This is in addition to recruiting healthcare professionals with western backgrounds who have 268 
expertise and experience of extended pharmacists’ roles and the need to invest in future 269 
pharmacy graduates with educational strategies that instil change agent roles to greatly 270 
enhance practice as hoped by one hospital pharmacist: 271 
“This is the time for change! if the older graduates didn’t change then the newer graduates 272 
should change everything” (Hospital Pharmacist Participant 2). 273 
274 
 Pharmacists’ perceptions of barriers275 
Pharmacists identified three themes related to the barriers for moving forward with 276 
collaborative practice. The first related to the patients’ negative perceptions. Participants in 277 
the different settings described their frustration with the patients’ view of them as merely 278 
‘vending machines’ for medications. Participants emphasised the lack of appreciation, respect, 279 
and trust by patients. They reported that patients viewed their interactions with the pharmacist 280 
differently from that with the physician. One hospital pharmacist said: 281 
“I think communication between pharmacists and patients will not be like patient physician 282 
relationship. Patients do not value pharmacists’ contribution as they do for physicians. This is very 283 
challenging” (Hospital Pharmacist Participant 1). 284 
The second identified theme was the status of the pharmacy profession. This related to 285 
perceived organisational concerns within the profession and included the lack of a grading 286 
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system for hospital pharmacists and the manner in which pharmacists are graded in the 287 
primary care setting. These systems were considered poor and provided a lack of incentive 288 
for career progression. This is contrary to what was perceived as career progression for nurses 289 
as illustrated by this quote: 290 
“Nurses have more opportunities than pharmacist and this is due to management supporting 291 
them, giving them new roles and responsibilities, they look after them very well, they put them 292 
into open new places, new work, this not happening between pharmacists and our management 293 
I don’t know why? … I can innovate, but the way is blocked for me!” (Hospital Pharmacist 294 
Participant 1). 295 
Additionally, in primary care the pharmacists’ role is mainly concerned with dispensing. The 296 
community pharmacists discussed how their setting is very much business oriented and how 297 
they lack the time to meet patients’ needs due to the large number of patients seen per day. 298 
Additionally, community pharmacists expressed concerns about lower salaries in comparison 299 
to other pharmacy sectors and that they will not be compensated for working 300 
interprofessionally. Another factor affecting the status of the pharmacy profession is the lack 301 
of pharmacist confidence which participants’ perceived had been sensed by patients. Some 302 
pharmacists felt less confident in giving drug information advice to other healthcare 303 
professionals. Participants attributed the lack of confidence perceived by some pharmacists 304 
to limited clinical knowledge and lack of clinical training as noted by one primary care 305 
pharmacist:  306 
“I know very well a lot of pharmacists and they may be very competent in their knowledge but they 307 
lack communication skills to transfer their knowledge even when dealing with physicians … they 308 
may have the right answer – but they (are) shy, okay, to give the real or the right answers … but as 309 
far as I know, a lot of pharmacists, they [are] hesitant to ask a doctor if there is a real, error in their 310 
prescription. Why? To my point of view because they didn’t have such training before. How to 311 
communicate with other professions, how to be self-confident when dealing with others…” (Primary 312 
Care Pharmacist Participant 1).  313 
Additionally, participants noted a lack of continuous professional development, training 314 
opportunities, and  protected time for training. 315 
The final theme identified was the current working practices and processes. This theme had 316 
five subthemes. It was evident in all the focus groups that hierarchy in the healthcare system 317 
was a barrier to implementing collaborative practice and this was frequently discussed. 318 
Pharmacists agreed that physicians are usually the leaders in the healthcare team and are 319 
the ‘maestro of the clinical rotation’. In many instances, the word ‘interference’ was used to 320 
describing pharmacists’ dealing with physicians. This led to pharmacists withdrawing from a 321 
more engaging interprofessional role. Community pharmacy participants were concerned that 322 
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when physicians communicated with them it was merely for stock checking or for a dispensing 323 
issue and not pharmacotherapy related queries. They were very cautious in their interaction 324 
and felt they needed to please the physician and manage expectations as highlighted by one 325 
community pharmacist: 326 
“Some doctors assume that I only call for business, or for something not available, not for the 327 
patient. So when I make a recommendation, some doctors feel I want to take his job I want to 328 
make overlay of his rule … physician feels threatened so when I talk with them, to ease the 329 
conversation, I would say: I know you know more than me” (Community Pharmacist Participant 330 
4). 331 
Moreover, participants reported that some physicians were threatened by the increasing 332 
therapeutic role of the pharmacist and preferred the traditional way of practice. One primary 333 
care pharmacist commented: 334 
“I want to say there is sometimes a problem between doctors and pharmacists about knowledge 335 
every time the doctors believes his knowledge is in higher level than pharmacists. This is a 336 
problem. Sometimes we are working together and we make recommendation based on 337 
evidence based practice and challenge them on what they have prescribed … sometimes they’ll 338 
listen, sometimes no, but the decision is coming from the doctor to the pharmacist” (Primary 339 
Care Pharmacist Participant 2). 340 
It emerged from the focus groups that pharmacists perceived that the power differential was 341 
greater within hospitals. It was claimed that nurses had lots of support from the hospital 342 
administration, giving them more opportunities to advance their professional careers. 343 
“I think it’s related to the power they have  (nurses) … hospitals are very much nurse dominated 344 
… For example, hospital projects are run by nurses and I would like to see pharmacist going 345 
beyond their usual practices and to be involved in running projects at hospital level” (Hospital 346 
Pharmacist Participant 1). 347 
Furthermore, healthcare professionals in Qatar come from a variety of cultures and countries 348 
with different backgrounds. This can enrich the practice experience, but participants agreed 349 
that this can also be one of the challenges. They noted disparities in knowledge, qualifications, 350 
attitudes, and experiences between health care professionals with some lacking 351 
interprofessional experiences. This was illustrated by one of the clinical pharmacist 352 
participants: 353 
“The working environment is very multicultural. Healthcare professionals are all from different 354 
nationalities, with different cultures. Now, sometimes this will enrich the environment but 355 
sometimes it will make it difficult to understand how to approach this doctor or this nurse. 356 
Because they come, they all come from different backgrounds, so for me, like how I’m going to 357 
communicate with someone who’s coming from India or from Philippines or US, UK … so at 358 
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the end of the day, these people have different beliefs and different attitudes and different 359 
cultures making it really difficult” (Clinical Pharmacist Participant 1). 360 
Additionally participants noted that many pharmacists’ educational backgrounds are not 361 
clinically-orientated but industry-focused. Therefore, IPE training is often non-existent. 362 
Furthermore, most pharmacists noted a lack of a collaborative practice but highlighted some 363 
emerging examples in some hospitals and slow introduction in primary care. However, there 364 
was no collaborative practice reported from the community pharmacists. 365 
“Currently there is nothing like interprofessional working that’s going around here. People are more 366 
or less very specific about their own professions. Very little interest and there are no movements to 367 
link people together in practice … in a community pharmacy our interaction with physicians or 368 
specialists or nurses are a matter of querying prescriptions. This is the only kind of interprofessional 369 
relationship we have but nothing like IPE ... I don’t see a scope for a real practical possibility” 370 
(Community Pharmacist Participant 1). 371 
372 
 Pharmacists’ recommendations373 
Two themes were identified for this category and this included changing the patient 374 
perceptions concerning the role of the pharmacist suggested by one hospital pharmacist: 375 
“We need to change the perception of the patient about pharmacist before the perception of 376 
the doctor or physician” (Hospital Pharmacist Participant 1). 377 
Secondly, to enhance the status of the pharmacy profession through training, providing more 378 
support for the profession and raising awareness about other professions. One of the hospital 379 
pharmacist participant believed the issue stems from the lack of competent pharmacist 380 
leaders: 381 
“It’s a problem in leaders; it would be good to get more pharmacist as leaders - innovative leaders 382 
will make things. If leaders are innovating, or think about the profession, (voices overlap), profession 383 
will advance and move forward leading to positive change” (Hospital Pharmacist Participant 1). 384 
385 
Discussion 386 
This mixed method study is the first comprehensive and explicit assessment of pharmacists’ 387 
perspectives, from different practice settings, towards IPE and collaborative practice in the 388 
State of Qatar, and perhaps worldwide. The results of the survey indicated that practising 389 
pharmacists had generally positive attitudes toward engaging in interprofessional learning and 390 
collaboration and this is replicated in other studies [24]. The follow-up focus groups allowed 391 
exploration of the pharmacists’ perceptions in relation to the advantages, barriers, and 392 
recommendations for the implementation of IPE and collaborative practice. 393 
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Findings from this study indicated that IPC had many professional related gains. Pharmacists 394 
may view IPC as an opportunity to improve their working conditions in the hope of reaching a 395 
similar status to their medical colleagues [52], increased professional fulfilment, and an 396 
improved professional image [22, 25, 53]. Collaborations are affected when there is role 397 
conflict, ambiguity and hierarchical differences between healthcare professionals. For 398 
example, pharmacists are concerned with appearing incompetent when relating to physicians; 399 
perceived as encroaching on boundaries of the physician’s roles; or feeling the other 400 
professional is not interested in collaboration [54]. The findings from this study highlighted two 401 
major observations which are discussed in detail below namely, the lack of existence of 402 
collaborative practice, hierarchy and power play.  403 
1. Lack of existence of collaborative practice 404 
This study revealed a poorer definition of IPE and IPC with more than one third of the 405 
respondents believing IPE to be shared learning. Although 56% of the respondents were able 406 
to identify the correct statement for IPC, they had poor knowledge of IPC models and research. 407 
Respondents rated their knowledge much less than their skill level and this was consistent 408 
with observations reported in another study using the same scale [45]. Additionally, more than 409 
a quarter of the survey respondents rated their skill level for communicating effectively as 410 
satisfactory or poor. This can be related to the practising pharmacists’ differences in 411 
educational backgrounds and lack of exposure to IPE during their undergraduate training, 412 
which was highlighted in the focus group discussion. The majority of pharmacists practising in 413 
Qatar are a heterogeneous expatriate group with most pharmacists graduating from 414 
programmes that focus on pharmaceutical sciences and industry rather than clinical pharmacy 415 
[42]. This, coupled with the current pharmacy practice infrastructure in Qatar, resulted in just 416 
over a quarter (27%, n=36) of respondents reporting that they spend the majority of their time 417 
in direct patient care activities [55]. These results concur with another study where insufficient 418 
opportunities to interact with other healthcare professionals was amongst the most common 419 
perceived barriers by pharmacists in Qatar to providing pharmaceutical care [56]. 420 
Additionally, although respondents gave their highest ratings to the importance of IPC as it 421 
relates to the effectiveness of their work, the results of the survey showed pharmacists were 422 
not satisfied with the process of IPC in their work settings. This was confirmed in the focus 423 
group, where most pharmacists indicated a lack of collaborative practice. This is similar to 424 
other reports in the literature where pharmacists noted poor communication and limited 425 
collaboration existing between them and members of the healthcare team [22, 24]. Clear 426 
differences exist between the practice settings with reports of collaboration emerging in some 427 
hospitals, and recently being introduced in primary care, but there was no evidence of 428 
collaborative practice in the community. This was anticipated and highlighted in the FIP report, 429 
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where the varying degree of collaboration by pharmacists with other healthcare professionals 430 
across the different care settings and within the same healthcare setting was noted [6]. It was 431 
promising that participants who had the opportunity to practise collaboratively were satisfied 432 
with their experience and reported positively about it.  433 
Time and financial limitations were identified as major barriers preventing pharmacists from 434 
learning more about IPC. These have also been reported as barriers for engaging in IPC [24, 435 
22]. The low salary, particularly for community pharmacists, and lack of compensation for 436 
providing pharmacy services demotivated pharmacists to move from their ‘shopkeeper’ image 437 
and utilise their knowledge and skills to enhance interprofessional working and patient care 438 
provision. Additionally, the perceived lack of time could be the result of believing that IPC is 439 
an additional task to their current job responsibilities rather than incorporating it into current 440 
working practices. Another barrier identified was the diverse educational backgrounds of the 441 
healthcare professionals, leading to divergent understandings of roles and responsibilities. 442 
Pharmacists also admitted that they lack confidence in dealing with other healthcare 443 
professionals. There were two factors associated with this: their perceived lack of clinical 444 
knowledge and their lack of skills in communicating with other healthcare professionals.  445 
 446 
Although many participants were not happy about the current collaborative process in their 447 
work settings, practising pharmacists were united in their optimism and were adamant that the 448 
future would be different, highlighting a number of current initiatives. Examples of the initiatives 449 
reported included the ‘Qatar National Vision 2030’. Furthermore, few of the hospitals in Qatar 450 
have integrated automated dispensing units (pharmacy robots) within their pharmacies, 451 
enabling pharmacists to assume more patient care responsibilities [57]. Additionally, the 452 
accreditation of practice settings ensures that the highest standard quality healthcare is being 453 
followed. Implementing an interprofessional culture usually requires a new generation of 454 
healthcare professionals [58]. Hence, pharmacy students graduating from the College of 455 
Pharmacy are expected to be the drivers for change enhancing the growth of clinically effective 456 
pharmacy practice services [57]. Community pharmacy practice in Qatar is still noted to be 457 
traditional and business oriented. However, the Ministry of Public Health has established a 458 
community pharmacy network supported by policies and procedures as per Qatar National 459 
Health Strategy (2011-2016). The goals of the community pharmacy strategy focus on 460 
providing high quality medication practice and the enhancement of healthcare services. [59]. 461 
Community pharmacists in Qatar have demonstrated their willingness to assume new roles 462 
for better patient care, which in turn will enhance the pharmacists’ public image [60]. 463 
2. Hierarchy and power play 464 
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A limited understanding of the pharmacist’s scope of practice by other professionals was 465 
perceived in both the survey and focus groups with frequent reference to physicians’ lack of 466 
awareness. However, evidence suggests that effective working relationships between 467 
healthcare professionals and previous positive experiences are important components for 468 
successful collaboration [61]. A hierarchical system is apparent in this study’s findings. 469 
Pharmacists articulated this with references related to: physicians being the ‘maestro of this 470 
clinical rotation’; pharmacists not wanting to interfere with GPs and concerned that 471 
collaboration may make matters worse; diverse expectations between pharmacists and 472 
physicians’; and the pharmacists’ perception that physicians believe their knowledge is much 473 
higher. These findings are similar to other Middle Eastern countries where healthcare is mainly 474 
physician driven and they are the main decision makers for patient care [62]. Observations 475 
from the mixed method study reported important communication taking place between 476 
physicians in contrast to fewer communications with the rest of the healthcare team. The 477 
suggested reasons for this was that physicians do not place value on expertise beyond their 478 
disciplines or the need for collaboration due to their limited awareness of others scope of 479 
practice [63]. Additionally, another study conducted in Qatar reported that physicians were not 480 
comfortable with pharmacists informing patients about cost-effective alternatives for 481 
prescribed medication or discussing with the physicians drug related problems. In the same 482 
study, physicians were not in favour of pharmacists being responsible for resolving drug-483 
related problems [64]. In another study conducted in Ireland, GPs questioned the role of the 484 
pharmacists in certain activities such as prescribing, which is interpreted as a ‘boundary 485 
encroachment’ [18]. This study concurs with such evidence in the wider literature and adds to 486 
the body of knowledge on pharmacists’ perspectives of collaborative working. 487 
Unfortunately, Qatar lacks a regulatory body for the pharmacy profession, [57, 55]. This was 488 
reflected in the participants’ frustration regarding their current job status and the lack of a 489 
grading systems for their career progression. This is in contrast to nurses, whom hospital 490 
pharmacists perceived to have immense support from the hospital administration, with many 491 
opportunities to advance. The lack of strong pharmacy leadership and the limited number of  492 
leaders were implicit in their comments. Pharmacists expressed a sense of hopelessness in 493 
their practice settings, attributing this to the hierarchal nature of the health system with 494 
physicians being the leaders. Pharmacists seemed to be adopting an attitude of defensiveness 495 
and subordination, and blaming physicians for their status [58]. A national body representing 496 
the pharmacy profession could be a way forward to alleviate this situation. 497 
There are a number of limitations to this current study. No formal registry for pharmacists 498 
practising in Qatar exists [55] to allow access to named pharmacists, and the College of 499 
Pharmacy database was used instead. Additionally, the survey was only offered in the English 500 
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language which may have discouraged pharmacists from participating, thus potentially limiting 501 
the response rate. However, previous surveys also used English as a language with no issues 502 
[56, 41]. The possibility of social desirability bias cannot be excluded from this survey and the 503 
focus groups. This did not seem to influence respondents’ views as highlighted in their 504 
comments. Only one focus group was conducted for each practice setting and there were 505 
similar emerging themes. Additionally, in mixed method research, the concept of the 506 
representativeness/saturation trade-off exists [65]. Therefore, in a sequential explanatory 507 
design, there is a greater emphasis on the quantitative stage, which is traded off with reaching 508 
saturation in qualitative data [65, 66]. Furthermore, the qualitative stages provided deeper 509 
insights into the posed research questions.  510 
The study provided a unique exploration of the pharmacy perspectives towards IPE and 511 
collaborative practice from a Middle Eastern context. Readiness assessment is recommended 512 
as a precursor to change implementation using the mixed method approach. Further work is 513 
needed to explore the perspectives of other healthcare professions’ attitudes and readiness 514 
toward IPE and collaborative practice to ensure a comprehensive understanding of readiness 515 
of healthcare professionals to IPE and IPC.  516 
 517 
Conclusion 518 
Although collaborative practice is yet to be implemented in many pharmacy practice settings 519 
in Qatar, pharmacists have already demonstrated a willingness and readiness to engage with 520 
interprofessional learning and collaborative practice. They perceive anticipated professional 521 
benefits as well as patient benefits. These findings are encouraging and should be taken as 522 
an opportunity to promote IPC in different work settings. Barriers to collaborative working have 523 
been discussed and these need to be investigated further and overcome before collaborative 524 
working can be fully achieved.  525 
 526 
Impact on Practice 527 
• The results of this study encourage stakeholders to call for a national structured training 528 
to promote IPC in practice settings for pharmacists and for the rest of the healthcare team 529 
in both postgraduate education and within continuing professional development 530 
opportunities.  531 
• These findings can be used to initiate discussions with key stakeholders on how to improve 532 
collaboration and promote it within the practice culture.  533 
16 
 
• The State of Qatar is taking significant steps towards improving the healthcare delivery 534 
system in all settings, yet attention needs to be focused on promoting collaborative 535 
practice.  536 
• With the landscape of health services rapidly changing in Qatar, and the advent of the 537 
Qatar vision 2030, the country requires pharmacists and all healthcare providers to utilise 538 
each other’s expertise to the maximum and work together towards patient-centred care.  539 
• Formal channels of communication need to be developed between healthcare 540 
professionals not just in Qatar but worldwide. 541 
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